VICENTE DAMIÁN
ESCUDERO VILAPLANA
Profesor asociado de Ciencias de la Salud
ESTHER
CHAMORRO DE VEGA
Profesora asociada de Ciencias de la Salud
Publicaciones en las que colabora con ESTHER CHAMORRO DE VEGA (9)
2022
-
Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare
Frontiers in Immunology, Vol. 13
-
Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study
Journal of Clinical Pharmacy and Therapeutics, Vol. 47, Núm. 12, pp. 2020-2029
-
Implementation and evaluation of a home pharmaceutical care model through Telepharmacy
Farmacia Hospitalaria, Vol. 46, pp. 36-46
-
Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey
Journal of medical Internet research, Vol. 24, Núm. 9, pp. e37445
-
The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search
Journal of Medical Internet Research, Vol. 24, Núm. 3
2021
-
COVID-19 in hospitalised patients in Spain: a cohort study in Madrid
International Journal of Antimicrobial Agents, Vol. 57, Núm. 2
2018
-
Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study
Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241
2017
-
Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project
International Journal of Clinical Practice, Vol. 71, Núm. 8
2016
-
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice
Annals of Pharmacotherapy, Vol. 50, Núm. 11, pp. 901-908